InstaPill Partners with Aché to Bring Advanced Oral Dispersing Tablet Solutions to Latin America

Bangalore: InstaPill Private Limited has announced a strategic partnership with Aché Laboratórios Farmacêuticos S.A., aimed at co-developing prescription pharmaceutical products using InstaPill’s proprietary lyophilized oral dispersing tablet (ODT) platform. The collaboration will initially focus on Brazil, with plans to expand across other Latin American markets.

Key Highlights

• InstaPill signs agreement with Aché to co-develop ODT-based prescription medicines.
• Partnership leverages InstaPill’s proprietary lyophilized ODT technology.
• Marks InstaPill’s first collaboration in Latin America, expanding access to advanced drug delivery solutions.

The partnership combines InstaPill’s technical expertise in oral lyophilizates with Aché’s strong market presence and distribution capabilities. Together, the companies aim to introduce innovative oral dispersing tablet solutions that improve patient convenience and compliance.

Ankit Gupta, CEO of InstaPill, said: “We are extremely pleased with our maiden partnership with Aché, which pairs InstaPill’s core technical capabilities in oral lyophilizates with Aché’s leading go-to-market expertise. This represents a significant step forward in our mission to expand InstaPill’s unique technology throughout Latin America.”